Please Subscribe to get a daily link to Pat's blog via email

Subscribe!

Your privacy is important to us. We will never spam you and keep your personal data secure.

Manitoba Approves Funding For Rev/Dex In Relapsed Multiple Myeloma Patients

Home/Manitoba Approves Funding For Rev/Dex In Relapsed Multiple Myeloma Patients

Manitoba Approves Funding For Rev/Dex In Relapsed Multiple Myeloma Patients

Good news! Looks like Canada is catching up to us on the myeloma therapy front:

Manitoba 8th Province to Approve Revlimid(R) Funding for Myeloma Patients

MONTREAL, Aug. 17 /CNW Telbec/ – Manitoba last week became the eighth province to approve funding for Revlimid(R) (lenalidomide) in combination with dexamethasone, as second-line therapy for the treatment of patients with multiple myeloma.

Feel good and keep smiling my Canadian friends!  Pat